M K Yunmbam Selected Research

Neoplasms (Cancer)

10/2001	Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian tumor cells.
1/2001	The bacterial polysaccharide tecogalan blocks growth of breast cancer cells in vivo.
11/2000	Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors.
3/2000	Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M K Yunmbam Research Topics

Disease

4	Neoplasms (Cancer) 10/2001 - 03/2000
3	Ovarian Neoplasms (Ovarian Cancer) 10/2001 - 03/2000
3	Carcinoma (Carcinomatosis) 10/2001 - 11/2000
1	Breast Neoplasms (Breast Cancer) 01/2001

Drug/Important Bio-Agent (IBA)

4	Cisplatin (Platino)FDA LinkGeneric 10/2001 - 03/2000
2	Proteasome InhibitorsIBA 10/2001 - 11/2000
2	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2001 - 11/2000
2	PlatinumIBA 10/2001 - 03/2000
2	DNA AdductsIBA 11/2000 - 03/2000
1	acetyl-leucinal-nor-leucinalIBA 10/2001
1	Heparinoids (Heparinoid)IBA 01/2001
1	lactacystinIBA 01/2001
1	tecogalanIBA 01/2001
1	Heparin (Liquaemin)FDA LinkGeneric 01/2001
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 01/2001
1	Polysaccharides (Glycans)IBA 01/2001
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2001
1	cisplatin-DNA adductIBA 11/2000
1	Antineoplastic Agents (Antineoplastics)IBA 11/2000
1	Histones (Histone)IBA 11/2000
1	ChromatinIBA 11/2000